Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Jan;265(1):185-191.
doi: 10.1097/SLA.0000000000001763.

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

Peter J Allen  1 , Deborah Kuk, Carlos Fernandez-Del Castillo, Olca Basturk, Christopher L Wolfgang, John L Cameron, Keith D Lillemoe, Cristina R Ferrone, Vicente Morales-Oyarvide, Jin He, Matthew J Weiss, Ralph H Hruban, Mithat Gönen, David S Klimstra, Mari Mino-Kenudson
Affiliations
Multicenter Study

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

Peter J Allen et al. Ann Surg. 2017 Jan.

Abstract

Objective: The aim of this study was to evaluate and validate the proposed 8th edition American Joint Committee on Cancer (AJCC) system for T and N staging of pancreatic adenocarcinoma.

Summary of background data: Investigators have questioned the clinical relevance and reproducibility of previous AJCC staging for pancreatic adenocarcinoma.

Methods: Prospective databases at Memorial Sloan Kettering (MSK), Massachusetts General Hospital (MGH), and Johns Hopkins Hospital (JHH) were queried for patients who had undergone resection for pancreatic adenocarcinoma. Patients who underwent a margin-negative (R0) resection, and who had previously undergone pathologic review, were included. Patients were staged according to 7th edition AJCC criteria, as well as the proposed 8th edition system that includes different definitions of tumor size (T) and nodal status (N). The dataset was randomly split into training and test sets.

Results: Two thousand three hundred eighteen patients were identified who met inclusion criteria. Recursive partitioning on the training set (n = 1551) identified statistically appropriate cutoffs for tumor size (<2.2 cm, ≥4.8 cm,) and nodal status (no positive nodes, 1 to 3 positive nodes, ≥4 positive nodes) that supported the proposed 8th edition changes. Median survival in patients staged as T3, N0 by the 7th edition definitions was different between institutions (median Center 1, 24 mo; Center 2, 37 mo; Center 3, 29 mo; P = 0.054). This difference was not observed when patients were staged as T3, N0 by 8th edition criteria. Stage, and stage-specific outcome (7th edition), on the test set revealed a predominance of patients (68%) within the IIB subgroup, and a concordance probability estimate (CPE) of 0.57 for stage-specific survival. When assessed with 8th edition criteria, no stage subgroup had a majority of patients, and the CPE was 0.58.

Conclusions: The proposed 8th edition changes for T and N classification were statistically valid and may allow a more reproducible system of T staging. This system also stratifies patients more evenly across stages without sacrificing prognostic accuracy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival by T-stage of 767 patients who underwent resection for node-negative pancreatic cancer. T-stage defined by AJCC 7th edition criteria.
Figure 2
Figure 2
Overall survival of 767 patients who underwent resection for node-negative pancreatic cancer. 2A: Overall survival stratified by institution. 2B: Overall survival of T3, N0 patients (AJCC 7th edition) stratified by institution. 2C: Overall survival of T3, N0 patients (AJCC 8th edition) stratified by institution.
Figure 3
Figure 3
Overall survival by T-stage of 525 patients who underwent resection for node-negative pancreatic cancer stratified by proposed AJCC 8th edition criteria (training set only).
Figure 4
Figure 4
Overall survival by number of positive nodes for all patients who underwent a R0 resection (training set, n=1551) stratified by proposed AJCC 8th edition criteria.
See this image and copyright information in PMC

References

    1. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. New York: Springer; 2010.
    1. Adsay NV, Bagci P, Tajiri T, et al. Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol. 2012;29:127–141. - PubMed
    1. Strobel O, Hinz U, Gluth A, et al. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg. 2015;261:961–969. - PubMed
    1. Murakami Y, Uemura K, Sudo T, et al. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg. 2010;211:196–204. - PubMed
    1. Basturk O, Saka B, Balci S, et al. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging. Ann Surg Oncol. 2015;22(Suppl 3):1187–1195. - PubMed